RankingsPricing
  1. US-listed companies
  2. AbbVie Inc.
  3. Financials
  4. Total current assets

AbbVie Inc.ABBV

Market cap
$409.5B
P/E ratio
SummaryFinancials
Period EndTotal current assets (Million USD)YoY (%)
Dec 31, 202425,582-22.48%
Dec 31, 202333,002+15.95%
Dec 31, 202228,463+1.92%
Dec 31, 202127,928+15.53%
Dec 31, 202024,173-51.18%
Dec 31, 201949,519+192.23%
Dec 31, 201816,945-20.16%
Dec 31, 201721,223+31.11%
Dec 31, 201616,187-0.78%
Dec 31, 201516,314+1.40%
Dec 31, 201416,088-9.86%
Dec 31, 201317,848

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)